MYCN and neuroblastoma: Our results support a model in which NIPBL promotes MYCN binding at enhancers and sustains its repressive influence on neuronal differentiation programs, thereby reinforcing the MYCN-driven oncogenic transcriptional network that maintains the neuroblastoma phenotype.